Report Detail

Pharma & Healthcare Global Emergency Contraceptives Market Insights, Forecast to 2025

  • RnM3087439
  • |
  • 09 March, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Emergency Contraceptives market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Emergency Contraceptives market based on company, product type, end user and key regions.

This report studies the global market size of Emergency Contraceptives in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Emergency Contraceptives in these regions.
This research report categorizes the global Emergency Contraceptives market by top players/brands, region, type and end user. This report also studies the global Emergency Contraceptives market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma

Market size by Product
Combined estrogen and progestin pills
Progestin-only (as Levonorgestrel) pills
Antiprogestin (as mifepristone) pills
Ulipristal acetate pills
Market size by End User
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Emergency Contraceptives market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Emergency Contraceptives market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Emergency Contraceptives companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Emergency Contraceptives submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Emergency Contraceptives are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Emergency Contraceptives market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Emergency Contraceptives Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Emergency Contraceptives Market Size Growth Rate by Product
      • 1.4.2 Combined estrogen and progestin pills
      • 1.4.3 Progestin-only (as Levonorgestrel) pills
      • 1.4.4 Antiprogestin (as mifepristone) pills
      • 1.4.5 Ulipristal acetate pills
    • 1.5 Market by End User
      • 1.5.1 Global Emergency Contraceptives Market Size Growth Rate by End User
      • 1.5.2 Hospital pharmacies
      • 1.5.3 Retail pharmacies
      • 1.5.4 Online pharmacies
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Emergency Contraceptives Market Size
      • 2.1.1 Global Emergency Contraceptives Revenue 2014-2025
      • 2.1.2 Global Emergency Contraceptives Sales 2014-2025
    • 2.2 Emergency Contraceptives Growth Rate by Regions
      • 2.2.1 Global Emergency Contraceptives Sales by Regions
      • 2.2.2 Global Emergency Contraceptives Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Emergency Contraceptives Sales by Manufacturers
      • 3.1.1 Emergency Contraceptives Sales by Manufacturers
      • 3.1.2 Emergency Contraceptives Sales Market Share by Manufacturers
      • 3.1.3 Global Emergency Contraceptives Market Concentration Ratio (CR5 and HHI)
    • 3.2 Emergency Contraceptives Revenue by Manufacturers
      • 3.2.1 Emergency Contraceptives Revenue by Manufacturers (2014-2019)
      • 3.2.2 Emergency Contraceptives Revenue Share by Manufacturers (2014-2019)
    • 3.3 Emergency Contraceptives Price by Manufacturers
    • 3.4 Emergency Contraceptives Manufacturing Base Distribution, Product Types
      • 3.4.1 Emergency Contraceptives Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Emergency Contraceptives Product Type
      • 3.4.3 Date of International Manufacturers Enter into Emergency Contraceptives Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Emergency Contraceptives Sales by Product
    • 4.2 Global Emergency Contraceptives Revenue by Product
    • 4.3 Emergency Contraceptives Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Emergency Contraceptives Breakdown Data by End User

    6 North America

    • 6.1 North America Emergency Contraceptives by Countries
      • 6.1.1 North America Emergency Contraceptives Sales by Countries
      • 6.1.2 North America Emergency Contraceptives Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Emergency Contraceptives by Product
    • 6.3 North America Emergency Contraceptives by End User

    7 Europe

    • 7.1 Europe Emergency Contraceptives by Countries
      • 7.1.1 Europe Emergency Contraceptives Sales by Countries
      • 7.1.2 Europe Emergency Contraceptives Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Emergency Contraceptives by Product
    • 7.3 Europe Emergency Contraceptives by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Emergency Contraceptives by Countries
      • 8.1.1 Asia Pacific Emergency Contraceptives Sales by Countries
      • 8.1.2 Asia Pacific Emergency Contraceptives Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Emergency Contraceptives by Product
    • 8.3 Asia Pacific Emergency Contraceptives by End User

    9 Central & South America

    • 9.1 Central & South America Emergency Contraceptives by Countries
      • 9.1.1 Central & South America Emergency Contraceptives Sales by Countries
      • 9.1.2 Central & South America Emergency Contraceptives Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Emergency Contraceptives by Product
    • 9.3 Central & South America Emergency Contraceptives by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Emergency Contraceptives by Countries
      • 10.1.1 Middle East and Africa Emergency Contraceptives Sales by Countries
      • 10.1.2 Middle East and Africa Emergency Contraceptives Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Emergency Contraceptives by Product
    • 10.3 Middle East and Africa Emergency Contraceptives by End User

    11 Company Profiles

    • 11.1 Genetics
      • 11.1.1 Genetics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Genetics Emergency Contraceptives Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Genetics Emergency Contraceptives Products Offered
      • 11.1.5 Genetics Recent Development
    • 11.2 Teva Pharmaceutical
      • 11.2.1 Teva Pharmaceutical Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Teva Pharmaceutical Emergency Contraceptives Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Teva Pharmaceutical Emergency Contraceptives Products Offered
      • 11.2.5 Teva Pharmaceutical Recent Development
    • 11.3 Uniprix
      • 11.3.1 Uniprix Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Uniprix Emergency Contraceptives Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Uniprix Emergency Contraceptives Products Offered
      • 11.3.5 Uniprix Recent Development
    • 11.4 Gavis Pharmaceuticals
      • 11.4.1 Gavis Pharmaceuticals Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Gavis Pharmaceuticals Emergency Contraceptives Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Gavis Pharmaceuticals Emergency Contraceptives Products Offered
      • 11.4.5 Gavis Pharmaceuticals Recent Development
    • 11.5 HRA Pharma
      • 11.5.1 HRA Pharma Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 HRA Pharma Emergency Contraceptives Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 HRA Pharma Emergency Contraceptives Products Offered
      • 11.5.5 HRA Pharma Recent Development
    • 11.6 Mankind Pharma
      • 11.6.1 Mankind Pharma Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Mankind Pharma Emergency Contraceptives Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Mankind Pharma Emergency Contraceptives Products Offered
      • 11.6.5 Mankind Pharma Recent Development

    12 Future Forecast

    • 12.1 Emergency Contraceptives Market Forecast by Regions
      • 12.1.1 Global Emergency Contraceptives Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Emergency Contraceptives Revenue Forecast by Regions 2019-2025
    • 12.2 Emergency Contraceptives Market Forecast by Product
      • 12.2.1 Global Emergency Contraceptives Sales Forecast by Product 2019-2025
      • 12.2.2 Global Emergency Contraceptives Revenue Forecast by Product 2019-2025
    • 12.3 Emergency Contraceptives Market Forecast by End User
    • 12.4 North America Emergency Contraceptives Forecast
    • 12.5 Europe Emergency Contraceptives Forecast
    • 12.6 Asia Pacific Emergency Contraceptives Forecast
    • 12.7 Central & South America Emergency Contraceptives Forecast
    • 12.8 Middle East and Africa Emergency Contraceptives Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Emergency Contraceptives Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Emergency Contraceptives. Industry analysis & Market Report on Emergency Contraceptives is a syndicated market report, published as Global Emergency Contraceptives Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Emergency Contraceptives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,603.60
      5,405.40
      7,207.20
      590,031.00
      885,046.50
      1,180,062.00
      325,143.00
      487,714.50
      650,286.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report